Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with dementia

numeracy1 - university of southern california2 - mediterranean and dash1 - latrepirdine1 - cognitive processes2 - cerebrovascular disease1 - protease enzyme1 - body mass index2 - behaviours redolent1 - signs of alzheimer's1 - gum disease1 - people with parkinsons1 - quantitative structural neuroimaging1 - dementia of the alzheimer type1 - quality sleep1 - brain insulin1 - cytokine storm1 - neuropsychological tests1 - cognitive function9 - amyloid plaque4 - progressive neurodegenerative disorder1 - dopamine deficiency1 - cholesterol1 - reversible dementia1 - dopamine-producing nerve cells1 - fragmentation of dementia1 - sporadic parkinson's disease1 - icd-101 - margaret thatcher1 - tomosyn1 -